










The Centre for Health Economics Research and Evaluation (CHERE) was 
established in 1991.  CHERE is a centre of excellence in health economics and 
health services research. It is a joint Centre of the Faculties of Business 
and Nursing, Midwifery and Health at the University of Technology, Sydney, in 
collaboration with Central Sydney Area Health Service. It was established as a 
UTS Centre in February, 2002. The Centre aims to contribute to the development 
and application of health economics and health services research through 
research, teaching and policy support. CHERE’s research program encompasses 
both the theory and application of health economics. The main theoretical 
research theme pursues valuing benefits, including understanding what 
individuals value from health and health care, how such values should be 
measured, and exploring the social values attached to these benefits. The 
applied research  focuses on economic and the appraisal of new programs or new 
ways of delivering and/or funding services. CHERE’s teaching includes 
introducing clinicians, health services managers, public health professionals 
and others to health economic principles. Training programs aim to develop 
practical skills in health economics and health services research. Policy 
support is provided at all levels of the health care system by undertaking 
commissioned projects, through the provision of formal and informal advice as 
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Objective: To identify the key methodological issues in the construction of 
population-level EQ-5D / Time Trade-Off (TTO) preference elicitation studies.  
 
Study Design: This study involves three components. The first was to identify 
existing population-level EQ-5D TTO studies. The second was to illustrate and 
discuss the key areas of divergence between studies, including the international 
comparison of tariffs. The third was to portray the relative merits of each of the 
approaches, and to compare the results of studies across countries.   
 
Results: While most papers report use of the protocol developed in the original 
UK study, we identified three key areas of divergence in the construction and 
analysis of surveys. These are the number of health states valued in order to 
determine the algorithm for estimating all health states, the approach to valuing 
states worse than immediate death, and the choice of algorithm. Finally, the 
evidence on international comparisons suggests differences between countries, 
although it is difficult to disentangle differences in cultural attitudes with random 
error and differences due to methodological divergence. 
 
Conclusion: Differences in methods are likely to obscure true differences in 
values between countries. However, population-specific valuation sets for 




Health care spending, as a proportion of gross domestic product (GDP) has 
increased over the past thirty years in developed countries. In the United 
States, this percentage increased from 7.6% in 1972 to 14.0% in 1992, to 
around 16.0% in 2004 
1, 2. This is not confined to health care systems with 
predominantly private funding. Publicly funded systems, as in the United 
Kingdom, and social insurance-based systems, as in France, have also 
witnessed large absolute and proportional increases in expenditures. As 
society's investment in health care increases, appropriate and transparent 
decision-making by policy makers becomes increasingly important. As a 
result, economic evaluation is used increasingly by health system decision-
makers in Australia and internationally to determine allocation of health care 
resources between services, and levels of subsidy. Public funding decisions 
require assessment of resource allocation across diverse diseases and 
treatments with varying impacts on health outcomes. Cost-utility analysis 
(CUA) is the main approach used to measure and value the impacts of 
treatments: the US Panel on Cost-Effectiveness in Health and Medicine 
recommends the use of quality adjusted life years (QALYs) 
3; the UK National 
Institute of Clinical Excellence has most commonly used CUA 
4, 5 and has 
recently recommended that it should be the preferred outcome measure; and 
CUA is increasingly used in Australia in the evaluation of pharmaceuticals and 
medical services. In the recently released PBAC guidelines, a preference is 
expressed for the use of CUA. 
 
The advantage of CUA is that it quantifies and values benefit from 
interventions across all fields of health and healthcare in a common metric 
(predominantly the Quality-Adjusted Life Year (QALY)), allowing decision-
makers to assess the relative value of many different demands for resource 
allocation. The time in a particular health state is weighted by a quality weight 
(utility weight) between zero (death) and one (full health) that reflects society’s 
willingness to trade-off between quality of life and survival. Weights less than 
zero reflect health states worse than death. QALYs are designed to allow 
comparisons across interventions with disparate outcomes, across different 
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health care conditions and population groups, thus providing information 
required by health policy makers.  While CUA is simple in concept, it presents 
challenges in practice. Eliciting valuations for all health states that may be 
relevant to a disease or intervention is time-consuming and costly. Further, 
comparison of valuations across interventions and diseases requires 
comparability of methods. 
 
The QALY approach requires an accurate description of the health outcomes 
associated with a chronic condition and a method for eliciting preferences for 
the health outcomes. A number of approaches for describing and eliciting 
preferences for health outcomes have been developed, but increasingly it is 
recognised that there is value in standardised methods for measuring and 
valuing health states for use in economic evaluation. The measurement of 
health-related quality of life (HRQoL) has become increasingly important for 
economic evaluations as cost-utility analysis has become the preferred 
method of investigating cost-effectiveness. In particular, the potential role for 
standardised instruments which allow for both description and valuation of 
quality of life is increasingly recognised. This contrasts with the approach that 
has been commonly used of development of scenario based vignettes based 
on clinical and quality of life data, which are then used as a basis for health 
state valuation. The QALY framework assumes that the value of a chronic 
health profile can be characterised by the product of life expectancy and 
HRQoL. Therefore, it is of paramount importance to consider how HRQoL can 
estimated in a way that represents improvements across the spectrum of 
potential interventions without bias.  
 
Multi-attribute utility (MAU) instruments such as the EQ-5D, the SF-6D, HUI 
(Health Utilities Index), and AQoL (Assessment of Quality of Life), have 
facilitated comparability. 
6, 7 These generic instruments comprise a descriptive 
quality of life instrument (a set of items or statements with multiple response 
categories that cover a range of dimensions of HRQoL) and a set of utility 
weights which reflect the strength of a community’s preferences for the health 
states. The utility weights are derived from a scoring algorithm that relates 
each health state described by the MAU instrument to a single number that 
2  
reflects the value of that health state. The scoring algorithm is usually 
generated by eliciting responses from a population sample using a scaling 
technique such as time trade-off (TTO), standard gamble (SG) or visual 
analogue scale (VAS).  Statistical methods are used to estimate a model that 
relates the responses derived from the scaling technique to the dimensions 
and levels in the descriptive system. This model is the basis of the scoring 
algorithm for the utility weights. For utility weights to be meaningful for 
economic evaluation, the scaling technique must reflect trade-offs individuals 
are willing to make between health outcomes. The numeraire for capturing 
such trade-offs has typically been time (for example, QALYs), with the time 
adjustment derived from one of the scaling techniques above.  The key 
advantage of MAUI approach is that it provides community based valuation of 
health states but direct contemporaneous description of QOL by patients who 
are experiencing the state. 
 
While the role of MAU instruments in economic evaluation is increasing, there 
remain a number of methodological issues associated with them. In particular, 
the applicability of a particular instrument depends on its capacity to reflect 
accurately the health state valuations associated with particular health states, 
and to capture and quantify the value of the change in quality of life 
associated with particular treatments. Recent reviews have noted that there 
are significant differences in the performance of different MAUIs. 
8 While this 
has been attributed to differences in the dimensions in the instruments and to 
the preference elicitation techniques, there has been relatively little critical 
appraisal of the methods of development of MAUI scoring algorithms.  In this 
paper, we examine these issues by considering the EQ-5D 
9.  We chose the 
EQ-5D because it is widely used and there are a number of different studies 
which have been undertaken to develop country specific scoring algorithms. 
Because the focus of this review is on one MAUI, we do not consider the 
psychometric aspects of the instrument, but rather focus on the methods for 
development of the scoring algorithm. Many of the issue we raise are relevant 
to other MAUIs. 
 
Overview of the EQ-5D 
3  




The EQ-5D is a tool developed by the Euroqol group (www.euroqol.org). The 
EQ-5D has five dimensions, intended to represent the major areas in which 
health changes can manifest. These areas are mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression (See Figure 1). Each 
dimension contains three levels, loosely termed ‘No Problems’, ‘Some 
Problems’, and ‘Significant Problems’. Thus, there are 3
5 = 243 potential 
states in the descriptive system. The TTO approach is used to value a 
selection of these states, and then to impute values for the remainder using 
simple regression. The use of TTO for valuing EQ-5D states is well described 
elsewhere (
9, 
10 etc). For states considered to be preferable to immediate 
death, a respondent is faced with a choice between ten years of a particular 
chronic health state defined in EQ-5D space with a period of x years in full 
health. The aim of the TTO is to identify a value of x for which the individual is 
indifferent in the choice. The value for the health is defined as x / 10. 
 
Our analysis of this EQ-5D / TTO approach involves two strands: Firstly, we 
look at how to elicit societal valuations for EQ-5D states under the standard 
TTO protocol. This paper identifies some key themes and issues that run 
across the population valuation studies. It then identifies some key themes 
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and issues that run across the literature base. Finally, it looks at international 
comparisons and discusses whether it is necessary to provide nationality-




The initial target of the study was to identify all large general population 
valuations studies employing the EQ-5D as the tool for describing health. 
EMBASE and MEDLINE were searched for such papers. To be considered for 
inclusion, the analysis had to present primary research in English and be 
published since 1995. Since it was expected that a proportion of good quality 
reports may be unavailable in peer-reviewed publications, the reference lists 
of papers identified in the main search were used to identify further studies. 
Since all of these identified non-peer reviewed publications were available on 
the EuroQol website (www.euroqol.org), the list of EuroQol Plenary Meeting 
Proceedings was scanned for further studies relevant to this work. To be 
included, a study had to attempt to value all 243 states described by the EQ-
5D. Beyond this constraint, we chose to be conservative in our approach to 
exclusion as we were seeking to identify divergence in approach. The one 
significant exclusion was that we decided not to consider EQ-5D studies that 
used the visual analogue scale (VAS) as the primary method for valuing 
states. These were excluded due to the potential for context bias 
11, and that 
states are not valued within a framework of choice. 
 
For each identified study, details most relevant to the analysis of the methods 
used were identified. Key areas for discussion were selected. These areas 
were the precise formulation of the algorithm, the number of states directly 
valued in the survey to generate weights, the method to value states worse 
than death, the influence of time preferences of results, and international 
comparisons in predicted values across EQ-5D space. 
 
The algorithms were compared by expanding the approach used by 
Busschbach et al. who compare the directly valued states in the UK, Germany 
and Spain.
12 For this, the UK results are used as the benchmark. The 
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predicted preference scores for the states under the UK algorithm are ranked 
in descending order. The preference scores under each of the other 
algorithms are generated, using the same ordering as the UK study. Using 
this approach, we can identify the tendency for countries to trade-off quantity 
of life for quality of life, and identify whether countries differ in their relative 




10 papers were identified (
13, 14, 15, 16 ,9, 17, 18, 19, 10, 20), of which 8 were published 
in peer-reviewed journals. It should be noted that there are, at present, no 
such results for Canada or Australia, two countries strongly supportive of the 
use of CUA in healthcare decision-making. 2 studies utilised the Visual 
Analogue Scale (VAS) as the primary method of valuation (
14, 16) so were 
excluded. The details of the remaining papers are given in the Appendix.  
 
Three significant methodological differences emerged regarding the survey 
structure, and the development of the algorithm. The first regarded the 
number of states that are needed to be directly valued to estimate valuations 
for the complete EQ-5D space. The second is the approach to valuing states 
considered to be worse than death. The third is the choice of the algorithm to 
model those states not directly valued. 
 
The Number of Directly Valued States 
 
Given that the EQ-5D has 243 individual possible states, it is unsurprising that 
no study has attempted to ask respondents to directly value each of these 
states. Therefore, the pertinent question becomes how best to form a 
representative fraction of the entire space which allows a good estimation of 
the remainder of the EQ-5D. Two approaches have been adopted to form this 
representative fraction. The original approach 
9, 21 valued 43 states, and each 
respondent directly valued a subset. The alternative approach was developed 
and uses 17 states, all rated by each respondent 
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Lamers et al. investigate these alternative approaches. 
18 The authors re-
analysed data from Dolan et al., 
9 simulating valuation studies in which 12, 17, 
22, 27, 32, 37 and 42 of the 42 states
1 are directly valued in samples of 50, 
100, 200, 300, 400, 600 and 800 per state valued. The outcome for each of 
these combinations is the mean absolute error (MAE) between the predicted 




As expected, the MAE is negatively associated with both the sample size and 
the number of health states directly valued. Additionally, they contrast these 
data with the results of Dolan et al. 
22 which suggests that not only does the 
17-state approach used by Tsuchiya et al. 
10 lead to a lower MAE than that of 
                                                 
1 Note that this deals with 42 since it is assumed that all respondents value 11111. 
2 MAE is a useful tool for estimating appropriateness as it shows the fit of the model to the data. 
However, other diagnostics might also be of value, for example out-of-sample or split-sample 
prediction (of directly valued states or otherwise). 
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Dolan et al. (1996), it leads to a lower MAE than if each respondent valued 17 
(or even 22) randomly assigned states from the 42. The mean correlation for 
the predicted and actual values if 22 states from 42 are randomly selected is 
0.986 (SD = 0.006) whereas the figures for the 17 states used by Tsuchiya et 
al. was 0.989 (SD = 0.002). 
10 Thus, the direct valuation of 17 states leads to 
more accurate prediction within a main effects model. 
 
A related question concerns whether the 17 and 43 state approaches are 
optimal in terms of study design. To allow equal precision in each of the effect 
estimates, it is necessary to have equal frequency of appearance for each of 
the levels. A disproportionate number of relatively better health states will lead 
to better precision at that end of the scale, and to less at the lower end. In 
addition, estimating interaction terms between dimensions becomes difficult 
as certain combinations of states rarely (or never) occur in directly valued 
states. In the 17 states directly valued by Tsuchiya et al,
10 and the 43 valued 
by Dolan et al. 
9, there is a disproportionate number of relatively better states 
i.e. level one attributes are over-represented. 
 
Valuing States Worse Than Death 
 
While it is plausible that the poorer states in the EQ5D might be considered 
worse than immediate death, certain methodological issues arise from 
generating an algorithm with a subset of states that include states worse than 
death. While anchoring death at zero and full health at one gives meaning to 
states that lie in that range, it is difficult to interpret different values below 
zero. The lack of a tool which is well-suited to this task means that existing 
papers have taken a range of approaches to valuing these states, some of 
which raise further problems. 
 
All papers begin from the same starting point, by asking respondents to 
choose between immediate death and a period of ten years of life, some of 
which is spent in the state worse than death, and some in full health. In the 
majority of papers, if the individual is indifferent between immediate death and 
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x years of the bad state followed by (10-x) years of full health, the score for 
the state worse than death is then calculated
3 in the following way
10 13 15 18 20 21 
 
Preference score (State worse than death) = (x / 10) – 1     (1) 
 
Since x is bounded by zero and ten, the preference score for states worse 
than death are bounded by 0 and -1. The one divergence from this orthodoxy 
is found in Shaw et al, 2005, for whom  
 
Preference score (State worse than death) = x / (10-x)     (2) 
 
They allowed the value for x to be between 0.25 and 9.75 years, meaning that 
the preference score is initially as low as -39. This leads to a dramatic 
asymmetry between states better than immediate death and those worse. 
This is important as it means that the impact of a brief period in the severest 
health state is of the same magnitude as a much longer period in full health. 
While a poor state such as this might be plausible, it could be argued that the 
uncertainty surrounding interpretation of states worse than death means that 
the value we place on these states should not have excessive influence on 
the final algorithm. Shaw et al suggested that states worse than death should 
be bounded by negative one so they then applied a linear transformation to 
the raw scores, constraining all scores to be in this range. 
19 The major 
problem with this linear transformation is that the valuations in this range are 
dependent on the minimum length of time the respondent is allowed to endure 
in the bad health state. If the minimum period allowable in the poor health 
state increases to, for example, one year, all negative values would be divided 
by nine. The effect of dividing the different health valuations by different 
factors (defined by the shortest allowable period in the poor health state) is 
illustrated in Figure 2. 
 
Figure 2: The effect of changing minimum time duration on valuations of 
states worse than death 
                                                 
3 Lamers et al appear to use a different algorithm but the reason for divergence is that they treat the 






























































As health moves away from zero towards negative one, the effect of this 
procedural variable becomes increasingly large, and suggests that this 
divergence from the orthodox position is not justified. 
 
The Construction of the Algorithm 
 
The benchmark UK study 
21 prefers a N1 model, in which the algorithm is a 
main effects model using dummy variables for levels in each dimension worse 
than ‘No Problems’, plus the N1 dummy variable, defined as 1 when any of 
the dimensions are at level 3 (the worst level). Thus,  
 
Valuation = 1 – (constant + ∑(dummyl,d * co-efficientl,d) + (dummyN1 *co-
efficientN1)) 
 
Aside from increased predictive value of the model with this interaction term 
9, 
the intuition behind using such a value is slightly uncertain. The first 
dimension to move to level 3 will have significant spill-over effects, perhaps 
not captured by the other dimensions. The need to adapt to a life with a 
severe impediment has a disutility which is a one-off. Thus, the second 
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dimension to move to level 3 will have a disutility (illustrated by the co-efficient 
associated with the respective dummy variable), but may have a lesser impact 
than if the move had occurred from a state with no pre-existing level 3 
problems. The reverse argument, claiming that the N1 term has no intuitive 
appeal, might argue that the extra predictive value is a remnant of the 
correction methods used to adjust states worse than death to constrain them 
between zero and minus one. Since these states are considerably more likely 
to have level 3 dimensions than the general set of states, it is arguable that 
applying an erroneous transformation, compressing negative values into too 
small a range, might be identified through lower co-efficients being applied to 
level 3 parameters beyond the first.  
 
Other than the N1 variable, most studies do not utilise interaction terms in 
their final algorithms. However, the intuitive argument in support of 
interactions can be illustrated using a number of examples (for example, the 
disutility of not being able to do usual activities may vary, depending on 
whether the person is mobile as this defines what usual activities consist of).  
A number investigate alternative model specifications containing interactions 
18, but generally (and perhaps surprisingly) find they do not improve the fit of 
the model (
20, 21, 10, 13).  
 
The final issue regarding the algorithm is the use and interpretation of the 
constant term. Conventionally, the intercept reflects the value of the function 
when all explanatory variables are zero (level 1 in the N1 model). However, in 
this case, this interpretation does not hold as 11111 is axiomatically described 
as full health and is anchored at 1. In the identified papers, there are two 
approaches in the discussion of the intercept. In the majority of studies, the 
intercept is allowed to vary from zero, and is interpreted as the disutility 
associated with not being at perfect health, independent of the disutility 
associated with the movement within the dimension per se (Dolan, 1996). This 
could be justified in the same way as the N1 variable was justified above. An 
alternative approach is taken in a recent US study (Shaw et al, 2005). The full 
algorithm used in this study in illustrated here: 
 
11  
Valuation = 1 – (constant + ∑(dummyl,d * co-efficientl,d) +  β1D1 + β2I2-squared 
+ β3I3 + β4I3-squared) 
   
where D1 is the number of dimensions not at level one beyond the first, I2 is 
the number of dimensions at level two beyond the first and I3 is the number of 
dimensions at level three beyond the first. The differences between this 
approach and the more commonly utilised N1 approach is that Shaw et al do 
not allow a constant term (since full health is anchored at 1) and they 
identified a broader group of statistically significant interaction terms, albeit 
specified in a different way. One criticism of this approach, and of the N1 
approach also, is that it is relatively blunt in its approach to interactions. For 
example, if we consider the interactions concerning dimensions being at level 
three, the effect of there being a number of dimensions at level three is 




The final question this paper looks at it is the extent to which the use of these 
different papers affects the preference scores associated with the 243 states 
in EQ-5D space, and thus whether the choice of algorithm is likely to alter 
resource allocation decisions. The respective betas are provided in the 
Appendix. Our results, comparing the wider range of countries using all states 
defined by EQ-5D space are shown in Figure 3 and Figure 4.  
 








































We have compared the algorithms to the benchmark in groups of three. When 
algorithms from Denmark, Germany, and the Netherlands are compared to 
13  
the UK study, they generate similar preference scores across the range of 
health states. Generally, these lie above the UK figures but follow the same 
trend. This suggests the various dimensions of the EQ-5D have the same 
approximate relative importance in these countries, but the absolute disutility 
attached to worsening in the health state in general is estimated to be lower. 
 
Divergence from this trend can be seen in the countries shown in Figure 4. 
The Spanish algorithm does not appear to systematically differ from the UK 
algorithm, but displays more variance from the UK algorithm than the Northern 
European results (suggesting different emphasis between dimensions). The 
Japanese results are below those of all other algorithms for mild health states 
(due to a large constant term in the N1 algorithm), but, for worse states, lie 
above all other algorithms. Under the Japanese algorithm, there are very few 
states considered worse than death. Additionally, the Japanese results show 
considerable variance relative to the UK figures. In comparing the Japanese 
results to the UK, this seems to be the result of a relatively high importance 
being associated with mobility, and a relatively low importance being 
associated with pain and discomfort, and anxiety and depression. The US 
study follows a similar pattern to the Japanese results but displays less 
variability relative to the UK. This unwillingness to trade off quantity of life for 
quality of life in Japan and the US means the spread of HRQoL scores is 
lower in these countries. As noted by Luo et al. and Noyes et al., this will lead 
to interventions being less cost-effective in CUA as the quality of life gain is 
likely to be relatively smaller. 
23 ,24 This is illustrated in Figure 5.  
 


















The uncertain element in interpreting these results is to identify whether the 
differences in algorithms are a result of genuine differences in national 
attitudes towards ill health, or whether they are the product of different study 
designs. In support of the former is the fact that Figure 3 suggests 
convergence between countries in a geographical locality (Northern Europe). 
However, we believe that, to firmly identify a trend in algorithms between 




This paper identifies a number of key methodological questions in the 
construction of population level EQ-5D TTO questionnaires. The number of 
states that need to be directly valued is considered, and the best solution may 
depend on whether it is worthwhile to look for interaction terms. We identified 
study design issues with the sets of states most commonly selected to be 
directly valued. The decision regarding number of states leads into a number 
of questions regarding the choice of algorithm. Then, we identified competing 
approaches for the valuation of states considered to be worse than death and 
identify that the approach used by Shaw et al. makes valuations heavily 
dependent on a parameter of model design (specifically the minimum period 




Whether country-specific algorithms are necessary is a difficult question which 
we have only partly addressed. There is clear divergence between countries 
in their valuations, both in terms of their willingness to trade quantity of life for 
quality, and their relative importance of the five dimensions of the EQ-5D. Our 
results suggest that a proportion of the divergence in algorithms is attributable 
to genuine cultural differences, which suggests that country-specific 
algorithms are of importance. This is particularly true in countries such as 
Canada and Australia which engage in substantial economic evaluation. 
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location (if not 
nationwide) 
Selection of health 
states 
Recruitment methods 
and withdrawal rates at 
different stages pre-
analysis  
Valuation method  Analysis method (including 
data exclusion) N.B. This is 
limited to the method for 






The sample size 
was 3395. Age 
greater than 18. 
They roll-backed the 
states by saying that 
UA1 cannot go with M3 
or SC3. 43 were roughly 
stratified by seriousness 
and each responder 
valued a sample of 13 
(11 random (2 “very 
mild”, 3 “mild”, 3 
“moderate” and 3 
“severe”) plus 
unconscious and 33333) 
 
No description of how 
they identified the wider 
set of 43 states. 
 
6080 addresses drawn 
from postcode address 
file. After non-residential 
properties and refusals 
were accounted for, 3395 
interviews were 
undertaken and 3337 
produced data suitable 
for analysis.  
1. Rating of own health state 
using EQ-5D and VAS. 
2. (Presumably socio-economic 
data collection since these were 
reported) 
3. Ranking of 15 states (13 plus 
11111 and dead) 
4. TTO ranking of 13 
 
States worse than dead – the 
choice was between dying 
immediately and spending a 
length of time (10-x) years in the 
health state followed by x years in 
full health (This is true in all 
papers unless stated) 
Data exclusion (after 
questionnaire) if  
1. Insufficient data 
2. All states rated worse than 
death 
3. No understanding of task 
 
All states better than dead 
were converted into a quality 
of life figure by dividing the 
number of years by 10. 
States worse than death were 
transformed using the 
formula y = -(x/10)-1 
 
Y = constant + β1MO + β2SC + 
β3UA + β4PD + β5AD + β6M2 
+ β7S2 + β8U2 + β9P2 + β10A2 
+ β11N3 
 
This is a main effects model 
without interactions, but with a 
term for whether each of the 
dimensions are at level 3, and 
one if any of them is at level 3. 
 
They tested for other model 
involving interactions but these 
did not improve the model 






The sample size 
was 543. Age 
greater than 20.  
 
Random selection 







They used a modified 
version of the MVH 
protocol containing 17 
health states
4. All 
respondents valued all 
health states. 
 
These 17 were described 
as “the minimum set of 
health states needed to 
estimate the value set”. 
Brief letters sent out to 
972 people. Of thee, 617 
agreed to take part in the 
survey. The survey was 
undertaken through face-
to-face interviews and 78 
respondents were 
rejected, leaving 543 
people suitable for 
analysis. 
1. Rating of own health state 
using EQ-5D and VAS. 
2. VAS evaluations of 14 
hypothetical health states 
expressed in EQ-5D 
3. Socio-economic background 
questions 
4. Ranking of 19 hypothetical 
health states expressed in EQ-5D 
5. TTO of the 17 hypothetical 
health states 
The 14 states were independent 
Data exclusion (after 
questionnaire) if: 
1. Completely missing TTO 
data 
2. Only 1 or 2 states valued 
3. All states given the same 
value 
4. All states worse than death 
For states better than dead, 
use the standard 
transformation. For worse 
than dead, use y=-(x/10)-1 
The base case algorithm was 
Preference value = PV = 1 – 
β0*const – β1*mob2 – β2*mob3 
– β3*sc2 – β4*sc3 – β5*ua2 – 
β6*ua3 – β7*pain2 –β8*pain3 – 
β9*mood2 – β10*mood3 – 
β11*N3 – (βn*interaction terms) 
- e 
 
They investigated using 
alternative models, looking at 
the number of dimensions at 
                                                 
4 These were 11112, 11113, 11121, 11131, 11133, 11211, 11312, 12111, 13311, 21111, 22222, 23232, 32211, 32223, 32313, 33323 and 33333 
19  
the local electoral 
registry 
(but occasionally overlapping) 
with the 19. The 19 are the 17 
given in the footnote, plus 11111 
and dead (these two are not part of 
the subsequent TTO) 
 
Six months was the lowest 
increment allowable. No 
description of ping-ponging. 
level 3 (C3), the square of the 
number of dimensions at level 
3 (C3sq), the existence of a 
dimension at level 1 (N1), the 
number of dimensions at level 
1 (C1) and the square of the 
number of dimensions at level 
1 (C1sq). 
 
With combinations of these 6 
interaction terms, the paper 
looks at 41 models. R
2 did not 
significantly improve under 
these alternatives and none 
removed heteroskedasticity. 
The best performers were the 
plain model without 
interactions, N3, C3sq and N3 
+ C3sq. 




The sample size 
was 975. Age 
unspecified 
 
1 primary health 









They used the 43 health 
states used in the UK 
General Population 
Survey (Dolan et al 
(1996)). Each respondent 
rated 13 states – not 
stated how these were 
selected from the 43. 
Since their aim was to 
compare Spanish and 
UK figures, likely to be 
the same process as 
Dolan (1996). 
1 930 individuals were 
contacted by letter, then 
by follow-up telephone 
call. 1 000 agreed to 
participation. Health state 
valuations were obtained 
in face-to-face 
interviews. 975 were 
identified as suitable for 
inclusion in data 
analysis. 
1. Rating of own health state 
using EQ-5D and VAS.  
2. Ranking of 13 health states plus 
unconscious (but not plus dead) 
3. They were then asked to put 
death in the ranking 
4. 13 states randomly ordered and 
respondent valued each (making 
sure first was not 33333 or 
unconscious). The ping-ponging 
went 5 years, 4/6 years, 3/7 years, 
2/8 years, 1/9 years) 
 
For states better than dead, 
the quality of life value was 
simply x/10. For states worse 
than dead, 2 different 
transformations were used. 
Firstly, y =-x/(10-x) 
Alternatively, y = (x/10)-1 
They chose the second one 
as more appropriate  
Preference value = PV = 1 – 
β0*const – β1*mob2 – β2*mob3 
– β3*sc2 – β4*sc3 – β5*ua2 – 
β6*ua3 – β7*pain2 –β8*pain3 – 
β9*mood2 – β10*mood3 – 
β11*unconscious – β12*N3 – 
(βn*interaction terms) – e 
 
The unconscious term might be 
a misprint since it can’t be 
included in an analysis as a 
dummy variable since it is 
incompatible with scores in any 
of the dimensions. Also, it is 
not mentioned in the regression 





The sample size 
was 300. Age 
between 18 and 
They used a modified 
version of the MVH 
protocol containing 17 
Quota sampling was 
used. The potential 
participants were 
1. Rating of own health state 
using EQ-5D and VAS. 
2. (Presumably socio-economic 
They looked at whether this 
smaller dataset was adequate 
for producing full quality of 
y = 1 – β0*const – β1*mob2 – 
β2*mob3 – β3*sc2 – β4*sc3 – 
β5*ua2 – β6*ua3 – β7*pain2 –
20  
Netherlands  75  health states. All 
respondents valued all 
health states. 
 
These 17 were described 
by Tsuchiya (2002) as 
“the minimum set of 
health states needed to 
estimate the value set”. 
 
approached by telephone 
and invited to participate. 
Face-to-face interviews 
at the office of the 
research company were 
undertaken and the 
participants each 
received a 20 Euro gift 
voucher. 
data collection since these were 
collected) 
3. Ranking of 17 states (plus 
11111 and dead) 
4. TTO process 
 
However, they used a computer 
for the TTO component, with the 
states presented in a random 
order. They describe the ping-
ponging process as ‘outward 
titration’. It is unclear whether this 
is the same process described in 
Tsuchiya, Badia etc.  
life figures for the entire 
range of EQ-5D states. 
 
β8*pain3 – β9*mood2 – 
β10*mood3 –– β11*N3 – 
(βn*interaction terms) + e 
 
A second model was 





The sample size 
was 339. Age 
greater than 15. 
 
The selection was 
based on postal 




Locations all in 




The health states 
selected followed the 
British sample analysis 
(Dolan (1997)) 
No detail of how many 
people were initially 
approached. 380 returned 
reply card indicating 
willingness to participate. 
These were assigned to 
interviewers, who 
contacted participants to 
arrange mutual date for 
meeting. If no date could 
be agreed, or if there was 
no reply in three 
consecutive attempts to 
contact them, the 
respondent was excluded. 
339 interviews were 
undertaken, of which 334 
were completed. 
 
A small reward was 
offered (20 Marks) 
1. Background information 
collection. 
2. VAS ranking of all selected 
states 
3. TTO assessment 
4. Self-assessment 
 
The ping-ponging was limited to 
whole years, other than in the case 
the indidividual was indifferent 
between ten years in state x with 
less than 1 year in full health. If 
the point of indifference was 
between 7 and 8, the authors 
assumed 7.5. 
 
Each interview lasted 43 
minutes. 
 
Data exclusion (after 
questionnaire) if: 
 
 They removed extreme 
values which eliminated 1% 
of the VAS scores and 1.5% 
of the TTO scores. 
 
 
Initially, the authors used an 





1. A variable for each EQ-5D 
dimension, showing a move 
from a less severe level to a 
more severe level. 
2. A dummy variable for a shift 
from level 2 to level 3 
3. An N3 dummy (for any level 
3) 
 
They investigated an 
alternative specification, using 
a multiplicative combination of 
the parameters. However, they 
find it is no better than the 





The sample size 
was 1 331 or 1 
332. Age 18-91 
(range rather than 
14 states used per 
respondent (22222, 
33333, 2 mild states, 8 
other states, 2 further 
4 075 random addresses 
were contacted, of which 
2 653 were at home 
within three attempts. 1 
The authors used face-to-face 
interview techniques. 
Complementary to this, computer-
assisted interviewing techniques 
Data exclusion if: 
 
1. All states given the same 
value 
Random effects model was 




limit)   states related to diabetes 
or heart disease patients), 
plus death and 11111. 
 
The authors used a split-
sample approach (4 
groups) to directly value 




face interviews at the 
respondents’ home.  
were used (with the interviewer 
inputting responses from 
respondent). 
 
1. Self-assessment using EQ-5D 
and VAS. 




2. Less than 2 states valued 
3. 11111 or death not valued 
4. Death valued higher than 
or equal to 11111 
 
For health states worse than 
death, the transformation 
was y =  –x(10-x) 
Yit = constant + β2x2,it + β3x3,it 
+…+ βkxk,it + ui + errorit  
 
Of the 12, three that had 
universally consistent 
parameters.
5 TTO3 (see 
footnote) had all significant 
parameters (p<0.001). 
However, since they wanted 
comparability with the UK-
tariffs, they went with TTO4 
(where all parameters were 
significant other than U2) 
 
The RE model, using this 
algorithm, suffered from mis-
specification and 
heteroskedasticity (both 





The sample size 
was 2 488. Age 
greater than 15 







Based in a high-
density suburb of 
Harare 
(Glenview). 
38 health states were 
chosen, based on Dolan 
(1996). Unconscious and 
dead not included, and 
two other states excluded 
due to an administrative 
error 
All residential plots in 
suburb (Glenview) were 
identified, and a random 
sample of 2 500 were 
chosen. 2 384 face-to-
face interviews were 
conducted in the houses 
without prior invitation. 
If no-one was present, 
the interviewer returned 
once at a later point. 
1. Self-assessment using EQ-5D 
and VAS. 
2. TTO on seven randomly 
selected states (from the 38) 
(Background information was also 
collected) 
Data exclusion if all states 
valued the same, fewer than 
three states valued, or if 






underrepresented, as were 
older people.  
 
Sample split into thirds, two 
thirds used as an internal 
sample. Data on these were 
used to predict the results of 
N3 model rejected as it lead to 
counter-intuitive results. 
 
They considered interaction 
effects (and found some 
significant effects). However, 
they argued that an algorithm 
with these interactions is 
unreliable. 
                                                 
5 TTO3 = f(MO, SC, UA, PD, AD, M2, S2, U2, P2, A2) where x2 means dimension x is at level 3, TTO4 = f (MO, SC, UA, PD, AD, M2, S2, U2, P2, A2, N3) where N3 
means any dimension at level 3, and TT10 = f(MO, SC, UA, PD, AD, M2, S2, U2, P2, A2, N2, N3) where N2 means any dimension at level 2. 
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The sample size 
was 4 048. Age 
was 18-99.3 
(range rather than 
limit) 
The authors used a split-
sample approach, with 
four modelling samples 
of approximately 900 
people and a validation 
sample of 400. 
 
Each group was assigned 
full health, ‘the pits’, 
unconscious and 
immediate death. 
Additionally, they were 
allocated 2 of 5 mild 
states (i.e. with one 
dimension at level 2) and 
9 of the remaining 36 
states. Therefore, all of 
the 43 states were valued 
by at least 900 people.  
 
12 000 addresses initially 
selected. From this list, 5 
237 people were selected 
for interview. 4048 
interviews were collected 
 
A small reward was 
offered ($30) 
1. Self-assessment using EQ-5D 
2. Ranking of health states 
3. Rating of these states on VAS 
4. Rating own health on VAS 
5. TTO on 13 states of the 15 
states (i.e. not including 11111 
and dead) 
6. Demographic questions 
7. Self-completion of the 15-item 
HUI-2/3 and rating own health on 
a 5-point scale ranging from 
excellent to poor. 
Data was excluded if: 
 
1. The respondent failed to 
value more than 1 health 
state. 
2. There was incomplete 
demographic information. 
3. If health states valued the 
same 
4. If all health states were 
valued as being worse than 
death. 
5. Respondent valued a 
health state using both sides 
of the board 
6. Respondent valued one or 
more incorrect health states 
based on their assigned set of 
health state cards 
7. Respondent valued one or 
more health states more than 
once. 
 
Included population rescaled 
to provide representativeness 
of the sample to the whole 
population in terms of race 
and sex. 
All algorithms tested included 
main effects. Interactions were 
considered but these generated 
models suffered from 




Rather than use a constant, they 
employed a D1 variable, 
representing the number of 
movements away from perfect 






dimensions were considered in 
a similar way. The variable I3 
represented the number of 
dimensions at level 3 beyond 





The square of this, as well as 
the similar I2 and I2-squared 
were also included. I2 was 
subsequently excluded as it 
caused multicollinearity. 
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